ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Psychiatry

Top Psychiatry Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PHILLIP DIAS-MANDOLY M.D.

Psychiatry

16,144

$1.72M

665
153 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$107
Average prescription price

Avg: $115

GUIDO BORIOSI MD

Psychiatry

13,875

$1.89M

678
135 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 22%

$136
Average prescription price

Avg: $115

THEODORE WILF M.D.

Psychiatry

12,192

$1.06M

561
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 22%

$87
Average prescription price

Avg: $115

TODD MUNESES MD

Psychiatry

11,721

$1.46M

583
65 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

2%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$124
Average prescription price

Avg: $115

RAVINDRA MEHTA M.D.

Psychiatry

10,626

$1.34M

672
312 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 22%

$126
Average prescription price

Avg: $115

PAUL GROSS MD

Psychiatry

10,419

$905K

816
443 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$87
Average prescription price

Avg: $115

CARLOS VELAS M.D.

Psychiatry

10,111

$1.02M

550
79 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $115

MANOJBHAI PATEL M.D.

Psychiatry

9,434

$1.8M

448
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$191
Average prescription price

Avg: $115

ANDREW LOPEZ M.D.

Psychiatry

9,397

$782K

265
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 22%

$83
Average prescription price

Avg: $115

HENRY WEHMAN M.D.

Psychiatry

9,307

$1.4M

367
33 are 65+

19%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 22%

$151
Average prescription price

Avg: $115

MARK PUTNAM MD

Psychiatry

9,263

$1.06M

546
138 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$115
Average prescription price

Avg: $115

JOEL LAST MD

Psychiatry

9,188

$665K

545
101 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 22%

$72
Average prescription price

Avg: $115

HARSHAD PATEL MD

Psychiatry

9,135

$1.12M

439
73 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 22%

$122
Average prescription price

Avg: $115

MATTHEW BEHAN DO

Psychiatry

9,127

$940K

432
65 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$103
Average prescription price

Avg: $115

ILAN LEVINSON M.D.

Psychiatry

9,092

$918K

568
89 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

2%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $115

MARY GALONSKI MD

Psychiatry

9,062

$1.11M

369
127 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$122
Average prescription price

Avg: $115

OSCAR URREA M.D.

Psychiatry

8,788

$1.37M

688
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$156
Average prescription price

Avg: $115

MIKHAIL VASSILENKO M.D.

Psychiatry

8,501

$840K

523
76 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 22%

$99
Average prescription price

Avg: $115

RONALD POPE D.O.

Psychiatry

8,431

$853K

310
40 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $115

PRABIR MULLICK M.D.

Psychiatry

8,381

$1.09M

296
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$130
Average prescription price

Avg: $115

ALEX THOMAS M.D.

Psychiatry

8,215

$926K

377
38 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$113
Average prescription price

Avg: $115

DENNIS WAYNE M.D.

Psychiatry

8,193

$878K

493
86 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$107
Average prescription price

Avg: $115

KISHORKUMAR DEDANIA M.D.

Psychiatry

8,102

$900K

442
65 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$111
Average prescription price

Avg: $115

MARK MATTA DO

Psychiatry

7,905

$1M

610
175 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$127
Average prescription price

Avg: $115

MATTHEW BERGER MD

Psychiatry

7,817

$1.2M

869
319 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 22%

$154
Average prescription price

Avg: $115

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank